These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 39147)

  • 1. Central actions of valproate sodium.
    Schmutz M; Olpe HR; Koella WP
    J Pharm Pharmacol; 1979 Jun; 31(6):413-4. PubMed ID: 39147
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.
    Kerwin RW; Olpe HR; Schmutz M
    Br J Pharmacol; 1980; 71(2):545-51. PubMed ID: 6781578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced accumulation of gamma-aminobutyric acid after chronic exposure to inorganic lead.
    Lasley SM; Wimbish GH; Lane JD
    Neurotoxicology; 1986; 7(2):527-40. PubMed ID: 3097593
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate.
    Farrant M; Webster RA
    Brain Res; 1989 Dec; 504(1):49-56. PubMed ID: 2513086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of sodium valproate on GABA levels in the rat brain].
    Gerardy J
    J Pharm Belg; 1984; 39(4):205-8. PubMed ID: 6439850
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium valproate exerts anti-conflict activity in rats without any concomitant rise in forebrain GABA level.
    Rasmussen KJ; Schneider HH; Petersen EN
    Life Sci; 1981 Nov; 29(21):2163-70. PubMed ID: 6798345
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic valproic acid therapy and synaptic markers of amino acid neurotransmission.
    Slevin JT; Ferrara LP
    Neurology; 1985 May; 35(5):728-31. PubMed ID: 3921873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
    Moroni F; Peralta E; Cheney DL; Costa E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):190-4. PubMed ID: 762651
    [No Abstract]   [Full Text] [Related]  

  • 10. D-tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons.
    Caputi L; Bengtson CP; Guatteo E; Bernardi G; Mercuri NB
    Synapse; 2003 Mar; 47(3):236-9. PubMed ID: 12494406
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.
    Löscher W
    Neurochem Res; 1993 Apr; 18(4):485-502. PubMed ID: 8097295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity.
    Baldino F; Geller HM
    J Pharmacol Exp Ther; 1981 May; 217(2):445-50. PubMed ID: 6785416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate induced changes in GABA metabolism at the subcellular level.
    Löscher W
    Biochem Pharmacol; 1981 Jun; 30(11):1364-6. PubMed ID: 6791653
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system.
    de Varebeke PJ; Niebes P; Pauwels G; Roba J; Korf J
    Biochem Pharmacol; 1983 Sep; 32(18):2751-5. PubMed ID: 6414480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between GABAergic and enkephalinergic systems: effects of sodium valproate on rat brain enkephalins.
    Vion-Dury J; Cupo A; Jarry T
    NIDA Res Monogr; 1986; 75():426-9. PubMed ID: 3123960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo.
    Rowley HL; Marsden CA; Martin KF
    Eur J Pharmacol; 1995 Dec; 294(2-3):541-6. PubMed ID: 8750716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neonatal brain fuel utilization by valproate and E-delta 2-valproate is not a consequence of the stimulation of the gamma-aminobutyric acid shunt.
    Bolaños JP; Medina JM
    Life Sci; 1994; 55(20):PL397-402. PubMed ID: 7968221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
    Bolaños JP; Medina JM
    Mol Pharmacol; 1993 Mar; 43(3):487-90. PubMed ID: 8450838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy.
    Gernert M; Fedrowitz M; Wlaz P; Löscher W
    Eur J Neurosci; 2004 Nov; 20(9):2377-86. PubMed ID: 15525279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.